What's in Jose Antonio Bernia Gil's pipeline?

Jose Antonio Bernia Gil has 2 drugs in our index: 2 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Jose Antonio Bernia Gil's portfolio?

Top competitors by shared drug class: First Affiliated Hospital, Sun Yat-Sen University.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/jose-antonio-bernia-gil.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Jose Antonio Bernia Gil — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Jose Antonio Bernia Gil pipeline: 2 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
ropivacaine,morphine chloride,epinephrine,ketorolac	ropivacaine,morphine chloride,epinephrine,ketorolac	marketed	Multimodal analgesic combination (local anesthetic + opioid + NSAID + sympathomimetic)	Sodium channels (ropivacaine), mu-opioid receptors (morphine), alpha/beta-adrenergic receptors (epinephrine), cyclooxygenase 1 and 2 (ketorolac)	Pain Management / Anesthesia
morphine ,ketorolac	morphine ,ketorolac	marketed	Opioid analgesic + NSAID combination	Opioid receptors (μ, δ, κ); COX-1 and COX-2 enzymes	Pain Management

Therapeutic area mix

Pain Management · 1
Pain Management / Anesthesia · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

First Affiliated Hospital, Sun Yat-Sen University · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Jose Antonio Bernia Gil:

Cite this brief

Drug Landscape (2026). Jose Antonio Bernia Gil — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/jose-antonio-bernia-gil. Accessed 2026-05-17.